Manufacturing Today - Summer 2010 - (Page 6)

COLUMN BY LYNN L. BERGESON many stakeholders question whether epa will carefully and consistently qualify what the test results mean – and do not mean. A Decade of Development Under Section 408(p) of the Federal Food, Drug and Cosmetic Act, EPA is required to develop a screening program to determine whether substances may have hormonal effects in humans. EPA has been working on various ways to implement this mandate for more than a decade. Based on the approach EPA finally adopted, the administration assesses the suitability of a chemical for Tier 1 “screening” based on a substance’s potential for human exposure. Once Tier 1 screening has have been generated and reviewed, chemicals needing no further testing exit the EDSP. Chemicals requiring additional testing must undergo Tier 2 tests. Last October, EPA identified the first set of chemicals to undergo Tier 1 screening. EPA selected 67 chemicals – 58 pesticide active ingredients and nine high production volume (HPV) chemicals used as pesticide inert ingredients – for which Tier 1 endocrine screening is required. The substances were selected based purely on their potential for human exposure, and not because any is known or likely to be an endocrine disruptor. Approximately 750 test orders were sent to approximately 450 companies. A second list of substances is required to be prepared by EPA pursuant to the 2010 Appropriations Act. EPA is expected to issue a list of at least 100 chemical substances by Oct. 30, 2010. The second list of substances will consist of pesticides from EPA’s registration review schedule and chemicals found in sources of drinking water. B USINESS VALUE Safe for Humans? EPA Orders Endocrine Screening ////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////// Hundreds of U.S. businesses have already received in the mail test orders issued by the U.S. Environmental Protection Agency (EPA) for initial endocrine screening under the Endocrine Disruptor Screening Program (EDSP). Hundreds more will receive orders later this year. How recipients respond to an EDSP test order can present challenging issues. This article explains why. M F G TOMO N EWS A CCOUNTIN C ONTENTS D IALOGUE K EY VARIAB P RICING F UNDEMEN B USINESS V 6 SUMMER 2010

Table of Contents for the Digital Edition of Manufacturing Today - Summer 2010

Manufacturing Today - Summer 2010
Global Strategies
Continuous Improvement
Smart Pricing
Supply Chain
Business Value
Moving Forward
Westmark Products
Byrne Dairy
Ultrafryer Systems Inc.
Wil-Rich LLC & Wishek MFG LLC
American Precision Fabricators
Aqua Products Inc.
Black Diamond Equipment
Columbian Home Products
Control Devices LLC
Endustra Filter Manufacturers Inc
Heil Trailer International
Assembled Products
Order-Matic Corp.
Professional Building Systems Inc.
Smart Start Inc
Bosal International
Ausco Products Inc.
Brodart Company
Cambrex Corp.
Chapin International Inc.
Cleveland Gear Co.
Consolidated Precision Products
Control Flow Inc.
Douglas Autotech Corp.
Fetzer Architectural Products
The FNA Group
Fourslide Spring and Stamping Inc.
G.A. West & Company
Great Lakes Power Group
Grimm Brothers Plastics
Legends Furniture Inc.
National Tube Supply Co.
Optex Systems Inc.
Sunburst Electronics
V.E. Enterprises Inc
W. Soule & Company
Manufacturing Tomorrow

Manufacturing Today - Summer 2010